HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

2nd Edition of International Heart Congress

June 20-22,2024 | Hybrid Event

June 20 -22, 2024 | Paris, France

Heart Congress 2024

 Michael E Merhige, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Michael E Merhige, State University of NY at Buffalo, United States

Background: External Counter Pulsation (ECP) is an FDA approved, noninvasive, treatment for patients with refractory angina, who are not candidates for low-risk interventional revascularization, such as those with chronic total coronary occlusion (CTO). ECP uses sequentially infl [....] » Read More

Yong Xiao Wang, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical Center, United States

Pulmonary hypertension (PH) is a common and devastating lung disease. The current primary medications for this disease are to use non-specific vasodilators, but patients do not always respond well to non-specific vasodilators. Voltage-dependent potassium channels and store-operat [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, Institute for Biotech & Global Health of RosBiotech and A.I. Evdokimov MGMSU, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare ser-vices, namely Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the re [....] » Read More

Miroslav Radenkovic, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Heart failure is a serious clinical syndrome with symptoms and signs provoked by a structural and functional cardiac abnormality, and coupled with elevated natriuretic peptide levels and evident pulmonary or systemic congestion. Regardless of outstanding improvements in the manag [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, Institute for Biotech & Global Health of RosBiotech and A.I. Evdokimov MGMSU, Russian Federation

Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Autoimmune myocarditis (AIM) can be defined as the autoimmune inf [....] » Read More

Prabode Weebadde, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Prabode Weebadde, Purdue University, United States

In the U.S., every year, about 800,000 people die due to cardiovascular diseases (CVD) or diseases related to the heart and blood vessels. Of those 800,000, 650,000 deaths were related to the heart, and 150,000 were related to blood vessels. To put it in another perspective, ever [....] » Read More

Ljudmila Stojanovich, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Ljudmila Stojanovich, University of Belgrade, Serbia

Introduction: A major cause of morbidity and mortality in the context of the antiphospholipid syndrome (APS) is the occurrence of thrombotic events, including cardiac involvement. Methods: We investigated 585 patients: 404 pts with PAPS followed up for an average of 44.00&plus [....] » Read More

Xin Li, Speaker at Heart Conferences
Oral Presentation (In-Person)
Xin Li, Chinese PLA General Hospital-Sixth Medical Center, China

Objective This article is in purpose of developing a multi-indicator combined diagnostic model of resting myocardial contrast echocardiography (MCE) to qualify myocardial perfusion dysfunction in coronary heart disease (CHD). Methods We performed resting MCE and stre [....] » Read More

Asma Ayadi, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Asma Ayadi, Tunisian Center for Nuclear Sciences and Technology, Tunisia

Arterial stiffness has emerged as a prominent marker of risk for cardiovascular disease. Few studies are interested in predicting symptomatic or asymptomatic arterial stiffness from hemodynamics and biomechanics parameters. Machine learning models can be used as an intelligent to [....] » Read More

Ajay Anil Bagalkot, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Ajay Anil Bagalkot, Aarupadai Veedu Medical College and Hospital, Pondicherry, India

MI with non-obstructive coronary arteries (MINOCA) is precipitated secondary to a group of vascular or myocardial disorders. MINOCA occurs in 5–15% of patients presenting with acute ST-segment elevation MI or non-ST segment elevation MI and prognosis is impai [....] » Read More

Mark Onsy Dimitry, Speaker at Cardiology Conference
Oral Presentation (In-Person)
Mark Onsy Dimitry, National Research Centre, Egypt

Background: Pulmonary arterial hypertension (PAH) is an uncommon disease and according to the Sixth International Symposium on Pulmonary Hypertension (PH) it is defined as an increase in mean pulmonary arterial pressure >20 mmHg with normal left ventricular filling pressures a [....] » Read More

Motahareh Ghodrati, Speaker at Heart Congress
Oral Presentation (In-Person)
Motahareh Ghodrati, Shahid Beheshti hospital, Iran (Islamic Republic of)

Many improvements have been made for the CPB device since the early 1950s. The design and construction of oxygenators is based on three basic components: the mechanism for blood circulation, the method of gas exchange of oxygen and carbon dioxide, and the mechanism for temperatur [....] » Read More

Jahanara Arzu, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Jahanara Arzu, Bangabandhu Sheikh Mujib Medical University, Bangladesh

Acute heart failure (AHF) is a major cause of morbidity and mortality worldwide. Although this is a common cause of dyspnoea, its diagnosis still represents a challenge. Lung ultrasound (LUS) is an emerging point-of-care diagnostic tool. Objective: The aim of the study was to ass [....] » Read More

Yanmin xu, Speaker at Heart Congress
Poster Presentation (In-Person)
Yanmin xu, Tian Jin Medical university , China

Background: To compare the effect of sacubitril/valsartan with benalapril on left ventricular remodeling in patients with acute myocardial infarction. Materials and Methods: 85 patients with acute ST segment elevation myocardial infarction who were treated with PCI in the Seco [....] » Read More

Roger H Coletti, Speaker at Cardiovascular Diseases Events
Keynote Presentation (Virtual)
Roger H Coletti, Interventional Health, PA, United States

Throughout the body blood flow is regulated by vascular tone secondary to local or neurologic control. However, in the musculoskeletal system, the effects of muscular contraction can lead to augmentation of restriction of local blood flow. While repetitive muscle contraction incr [....] » Read More

Pedro A Jose, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Pedro A Jose, The George Washington University of School of Medicine & Health Sciences, United States

Globally, hypertension is the number one risk factor for death, affecting more than 1 billion people. Hypertension is the result of the interactions among genetics, epigenetics, environment, and lifestyle. The long-term regulation of blood pressure (BP) rests on renal and non-ren [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Dyslipidaemia comprises  of abnormal lipid components  and  refers mainly to  increased levels of  LDL, non HDL particles and triglycerides while  decreased  levels of HDL Dyslipidaemia is a  common and independent  modifiable risk fac [....] » Read More

Tahmineh Azizi, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Tahmineh Azizi, University of Wisconsin, United States

In this study, we explore the possibility that ECG recordings belong to class of multifractal process for which a large number of scaling exponents are required to characterize their scaling structures. We use the BIDMC Congestive Heart Failure database including long term ECG re [....] » Read More

Ayisha Zaka Bashir, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Ayisha Zaka Bashir, Children’s Hospital and Medical Center, Omaha, Nebraska, United States

Peripheral artery disease (PAD) is a cardiovascular disease affecting more than 8.5 million Americans over the age of 40 years and is prevalent in the geriatric cardiology population. PAD is a manifestation of systemic atherosclerosis, characterized by atherosclerotic blockages o [....] » Read More

Iris Panagiota Efthymiou, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Iris Panagiota Efthymiou, University of East London, United Kingdom

The pursuit of cardiovascular wellness is of paramount global concern, touching the lives of many individuals and societies. Understanding the intricate interplay between economics and behavior in the context of heart health is pivotal for crafting effective strategies to mitigat [....] » Read More

Paraskevi Theofilou, Speaker at Heart Conferences
Oral Presentation (Virtual)
Paraskevi Theofilou, General Hospital of Thoracic Diseases SOTIRIA, Greece

Exercise is an important factor of rehabilitation in heart failure patients, improving several indicators of disease prognosis and functional capacity. The aim of the present study was to examine the effect of a cardiorespiratory rehabilitation program on the physical and mental [....] » Read More

Helen Senderovich, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Helen Senderovich, Baycrest Health Sciences, Canada

Introduction Congestive heart failure (CHF) is an increasingly prevalent terminal illness in a globally aging population. Despite optimal medical management, prognosis remains poor – a fact seldom communicated to patients and/or their families.  Evidence suggests nume [....] » Read More

 Maria Borrell, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Maria Borrell, Sant Pau Institute for Biomedical Research, Spain

Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) and Low-Density Lipoprotein Receptor (LDLR) downr [....] » Read More

Xueying Tian, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Xueying Tian, Fudan University, China

Neovascularization of the ischemic myocardium following infarction is vital for the survival of cardiomyocytes and prevention of heart failure. However, the intrinsic revascularization following ischemic injury in the heart is inadequate to restore blood flow to the infarcted myo [....] » Read More

Samir Morcos Rafla, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Samir Morcos Rafla, Alexandria University, Egypt

Most palpitations in pregnancy are benign and usually occur due to atrial or ventricular premature complexes. Careful consideration should be given to the gestation stage and the patient's hemodynamic state. In hemodynamically stable pregnant patients with acute onset of [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry Of Health, Egypt

Background: Arrhythmias are one of the most serious disorders in cardiovascular and clinical medicine. Understanding the pathogenesis and mechanisms of arrhythmias is very advantageous to the appropriate management and treatment of all arrhythmia types. The “Graded phenomen [....] » Read More

Will be updated soon......